SIG Brokerage’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

SIG Brokerage’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-39,500	Closed	-$3.96M	–	904
2025 Q3	$3.96M	Sell	39,500 -1,200	-3%	-$108K	0.11%	150
2025 Q2	$3.38M	Buy	+40,700	New	+$3.25M	0.09%	156

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

SIG Brokerage's XBI Position: Q3 2025 in Review

SIG Brokerage sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 60,067 shares — an estimated $5.41M sold.

SIG Brokerage first reported a position in XBI in Q1 2025 and held it in 2 quarters. The position peaked at $4.98M in Q2 2025. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

SIG Brokerage reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
SIG Brokerage sold 60,067 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $5.41M.
SIG Brokerage first reported a position in State Street SPDR S&P Biotech ETF in Q1 2025 and held it in 2 quarters.
SIG Brokerage's State Street SPDR S&P Biotech ETF position peaked at $4.98M in Q2 2025.
656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on SIG Brokerage's 13F filing for Q3 2025, filed 14 Nov 2025.